Islamic Microfinance: A Catalyst for Small Business Empowerment in Pakistan
Chartered Management Accountant Journal · 2025-04 · 34 (2) · 50-52
DOI: 10.65969/ma_3402-08.50 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chartered Management Accountant Journal, 2025-04. Verfasst von Sarah Safdar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This article emphasizes the significance of Islamic microfinance in empowering Small and Medium-Sized Enterprises (SMEs) in Pakistan, which contribute nearly 40% of GDP and employ 80% of the Non-Agricultural Workforce. Despite their importance, SMEs struggle to obtain formal credit due to conventional banks viewing them as high-risk. The article emphasizes that the firstly, Islamic microfinance offers a culturally appropriate solution by adhering to Shariah principles, prohibiting interest, and promoting asset-backed financing through instruments like Murabaha and Musharakah. Secondly, it enhances financial inclusion for marginalized groups and provides ethical financial options, as demonstrated by successful initiatives like the Akhuwat Foundation. Despite challenges such as low public awareness and a lack of regulatory frameworks, the article advocates for awareness through education, supportive regulations, and the use of technology to expand access to microfinance to support innovation in SMEs and reduce poverty in Pakistan.
Zitieren
APA
Safdar, S., & ACMA (2025). Islamic Microfinance: A Catalyst for Small Business Empowerment in Pakistan. Chartered Management Accountant Journal, 34(2), 50-52. https://doi.org/10.65969/ma_3402-08.50
Vancouver
Safdar S, ACMA. Islamic Microfinance: A Catalyst for Small Business Empowerment in Pakistan. Chartered Management Accountant Journal. 2025;34(2):50-52. doi:10.65969/ma_3402-08.50
BibTeX
@article{Safdar2025,
author = {Safdar, Sarah and ACMA},
title = {Islamic Microfinance: A Catalyst for Small Business Empowerment in Pakistan},
journal = {Chartered Management Accountant Journal},
year = {2025},
volume = {34},
number = {2},
pages = {50--52},
doi = {10.65969/ma_3402-08.50}
}
EUVIMED